A detailed history of Sound Income Strategies, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Sound Income Strategies, LLC holds 3,068 shares of IBRX stock, worth $7,577. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,068
Previous 1,100 178.91%
Holding current value
$7,577
Previous $3,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025

BUY
$1.89 - $3.44 $3,719 - $6,769
1,968 Added 178.91%
3,068 $8,000
Q1 2025

Apr 17, 2025

BUY
$2.32 - $3.9 $2,552 - $4,290
1,100 New
1,100 $3,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $989M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Sound Income Strategies, LLC Portfolio

Follow Sound Income Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.